STERIS plc (NYSE:STE) Shares Sold by Rodgers Brothers Inc.

Rodgers Brothers Inc. lessened its holdings in shares of STERIS plc (NYSE:STE) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,514 shares of the medical equipment provider’s stock after selling 61 shares during the period. Rodgers Brothers Inc.’s holdings in STERIS were worth $722,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in STE. Avalon Trust Co bought a new stake in STERIS during the 4th quarter valued at $30,000. Human Investing LLC bought a new stake in shares of STERIS during the fourth quarter valued at about $31,000. Anfield Capital Management LLC lifted its holdings in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division grew its position in STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC increased its stake in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Trading Up 1.9 %

STERIS stock opened at $227.14 on Tuesday. The firm has a market cap of $22.32 billion, a price-to-earnings ratio of 48.22 and a beta of 0.92. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The firm’s 50 day moving average price is $222.86 and its two-hundred day moving average price is $221.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were given a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on STE shares. Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens restated an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.